Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T71001 | GSK-598809 | ||
GSK598809 is a selective D(3)R antagonist recently progressed in Phase I trials. GSK-598809 may decrease the rewarding effects of contextual cues associated with drug intake preclinically, which may reduce drug craving in humans. | |||
T10062 |
(-)-GSK598809
1S,5R-GSK598809 |
Others | Others |
(-)-GSK598809 is an isomer of GSK598809 that is a potent and selective antagonist of dopamine D3 Receptor. | |||
T71634 |
GSK-598809 L-tartrate
|
||
GSK-598809 L-tartrate is an acute D3 antagonist. | |||
T11496 |
GSK598809
|
Others | Others |
GSK598809 is a selective and potent dopamine D3 Receptor (DRD3) antagonist (pKi: 8.9). |